Welcome to the new scientist and researcher reference section. Your one-stop shop for the essential resources you need to advance your career.

SNMMI 2018 Future Leaders Academy

The SNMMI Future Leaders Academy is the most recent addition to the SNMMI leadership development strategy. The SNMMI Future Leaders Academy training focuses on setting a clear plan for increasing leadership abilities by developing the necessary skills and organizational expertise to enhance performance and ultimately evolve into a leader both within the nuclear medicine and molecular imaging community and the society.

The academy will also help you to gain knowledge in fundamental leadership techniques from professionally recognized leadership groups and current SNMMI leaders.

Learn more about the Future Leaders Academy HERE.  

The Future Leaders Academy will be held January 25-28, 2018 in conjunction with the SNMMI Mid-Winter Meeting in Orlando, FL. By submitting an application you are affirming your availability on these dates and your willingness to attend the academy. If accepted, it is preferred that you make arrangements to stay for the entire Mid-Winter Meeting.  

All applications must be received by September 1, 2017, 5:00 pm (ET) 

Coding and Reimbursement

The most up-to-date and comprehensive source for nuclear medicine coding and reimbursement information on the web. Please note that ALL information and materials within the SNMMI Coding Corner are direct products of the SNMMI Coding and Reimbursement Working Group.

For Hospitals (APCs, IPPS) Find general coding and reimbursement information for hospitals.

For Private Practices (RBRVS) Find general coding and reimbursement information for professionals in private practices.

Coding and Reimbursement Q&A This easy to use feature contains over 100 questions and answers related to topics such as cardiac, endocrine, neurology, nuclear medicine-related drugs, oncology, PET, PET/CT, radiopharmaceuticals, and more!

Dose Optimization

In nuclear medicine and molecular imaging, small amounts of radioactive agents are administered to the patient to allow the physician to examine molecular processes within the body. These procedures are highly effective, safe and painless diagnostic tools that present physicians with a detailed view of what’s going on inside an individual’s body at the cellular level. For more than 60 years, these studies have been used to evaluate practically all systems within the body, including the heart and brain, as well as to image many types of cancer.

SNMMI has a large body of knowledge in dose optimization that is continually growing and developing. The dose optimization website presents a wide variety of resources, including SNMMI journal articles, educational offerings, media-related information, links to useful websites and more.



The practice guidelines help to identify those elements of the procedure that are most important in obtaining a high-quality examination, while simultaneously controlling costs. Use of standardized procedures will increase the applicability of clinical research among multiple institutions, in turn, increasing the value of research studies, particularly in the field of technology assessment. In the interest of creating strong, comprehensive documents, some guidelines were formally adopted by SNMMI in collaboration with other professional organizations.

View Guidelines.

Focusing on the Future of Molecular Imaging

SNMMI's Center for Molecular Imaging Innovation and Translation is an organizational component within the SNMMI that is dedicated to all aspects of molecular imaging in the detection and management of disease. The center is currently facilitating initiatives to bring molecular imaging discoveries from the lab to the patient and to advance "personalized" medicine.

Access resources.

The Clinical Trials Network’s mission is to advance the use of molecular imaging radiopharmaceuticals in clinical trials through standardization of chemistry and imaging methodology. This includes using imaging radiopharmaceuticals during the course of drug development, as well as bringing new agents to regulatory approval. Click here to learn more about the CTN’s Oncology and Neurology Scanner Validation programs, ongoing efforts to harmonize reconstruction parameters in oncology clinical trials, and other services that CTN offers to help scientists advance their research.

Educational Offerings

SNMMI educational programs are designed to meet the professional development needs of scientists involved in nuclear medicine and molecular imaging endeavors. 

Visit the SNMMI Learning Center.

Additional Resources

  • October 16, 2017Venkatesh Murthy, MD, PhD, Receives ASNC Top Clinical Research Award

    Venkatesh Murthy, MD, PhD, associate professor at the University of Michigan, was one of two scientists to receive an American Society of Nuclear Cardiology (ASNC) inaugural award for best clinical abstract at the ASNC Annual Scientific Session. His abstract on the effects of nuclear cardiology laboratory accreditation on patient outcomes was funded by the Intersocietal Accreditation Commission.
    (Member News)

  • October 11, 2017Norman E. Bolus, MSPH, CNMT, FSNMMI-TS, Receives Southeastern Chapter’s Marshall Brucer Award

    The Southeastern Chapter of the Society of Nuclear Medicine and Molecular Imaging (SECSNMMI) presented Norman E. Bolus, MSPH, CNMT, FSNMMI-TS, with the Marshall Brucer Award, the highest honor that the chapter can bestow upon a member, during the SECSNMMI Annual Meeting, held October 6-8, 2017, in Birmingham, Alabama.
    (SNMMI News)

  • October 10, 2017SNMMI-TS Leadership Academy Receives AAMSE Profiles of Excellence Award

    The SNMMI-TS Leadership Academy has received the American Association of Medical Society Executives’ (AAMSE) 2017 Profiles of Excellence Award in the Leadership Category. The SNMMI-TS Leadership Academy, which celebrated its 10th anniversary this year, is a two-day course that hones the leadership and organizational skills of participants, helping them become more engaged and effective leaders at the regional and national levels.
    (SNMMI News)

  • October 5, 2017Novel PET Tracer Identifies Most Bacterial Infections

    Stanford University medical scientists have developed a novel imaging agent that could be used to identify most bacterial infections. The study is the featured basic science article in The Journal of Nuclear Medicine’s October issue.
    (Press Release)


"F-DOPA: Its Use in CHI and Regulatory Status"

Speaker: Lisa States
Date: October 19, 2017 at 3:00 pm ET 

Join Lisa States for a one hour webinar: F-DOPA: Its Use in CHI and Regulatory Status. This webinar will review the current clinical management of Congenital Hyperinsulinism (HI) and the role the 18F-DOPA scan plays in the care of neonates and infants with medically unresponsive hyperinsulinemic hypoglycemia.

Featured Resources

  • SNMMI Councils/Centers Internship Program Call for Applications

  • Guidance

    Tools, supported by evidence, to harmonize the practice of nuclear medicine using a progressive and safe approach.

  • Nuclear Medicine and Molecular Imaging Week: October 1-7, 2017

    Happy Nuclear Medicine Week! Encourage community members to take pride in their profession – recognizing their colleagues for their hard work and promoting nuclear medicine to the entire medical community as well as to the public.

  • Legislative Issues

    SNMMI monitors multiple federal legislative issues and provides resources including issue summaries, letters to Congress, and analysis. Most of this information is in the government relations news section of this web site.

  • SNMMI Books

    Learn more about books published by the Society of Nuclear Medicine and Molecular Imaging and the Technologist Section.